Histomolecular Profiling in Small-Bowel Diseases
- Sponsor
- Tampere University Hospital
- Study ID
- NCT07556328
- Status
- Recruiting
Conditions
- Celiac Disease
- Refractory Celiac Disease
- Small Bowel Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
This prospective cohort study aims to establish reliable histological reference values for normal small-bowel mucosa, improve histological diagnostic quality in celiac disease, and develop an advanced molecular profile for disease diagnosis and treatment response evaluation. The study will collect duodenal biopsies from three groups: healthy controls undergoing clinically indicated gastroscopy, patients referred for primary celiac disease diagnostics, and patients with small-bowel mucosal injury unresponsive to a gluten-free diet. Patients will undergo routine clinical assessment via standard pathology review of diagnostic biopsies. Biopsies will be analyzed using digital morphometry, AI-based image analysis, RNA sequencing (transcriptomics), and intestinal organoid cultures.
Key Dates
- Start date
- Nov 1, 2025
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Group 1 - Healthy Controls (n = 130)Adults ≥18 years undergoing clinically indicated gastroscopy (e.g., reflux symptoms) with no suspicion of celiac disease and negative celiac antibodies (anti-transglutaminase and/or anti-endomysium).
- Arm: Group 2 - Celiac Disease Diagnostic Group (n = 130)Adults referred for primary celiac disease diagnostics requiring duodenal biopsy, in accordance with standard care guidelines.
- Arm: Group 3 - Refractory Small-Bowel Injury Group (n = 40)Adults with small-bowel mucosal injury (villous atrophy) that does not respond to a gluten-free diet, referred for endoscopy to exclude ongoing histological damage.
Primary Outcome Measure
Villus-to-crypt ratio [ Time Frame: Research biopsy obtained at time of endoscopy; digital morphometry performed through study completion (up to December 31, 2025) ]
Central Contacts
- Juha Taavela+358443400330
Related Studies
- Celiac Disease Genomic Environmental Microbiome and Metabolomic StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI CapsuleEnrolling By Invitation · Massachusetts General Hospital · Boston, Massachusetts
- General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care DeliveryRecruiting · Sanford Health · Bemidji, Minnesota
- Combined Antibody Screening for Celiac and Diabetes EvaluationEnrolling By Invitation · Pacific Northwest Research Institute · Seattle, Washington